RTTNews预览Medpace即将发布二季度财报，未披露新的业绩结果或公司增量信息

Medpace Holdings, Inc. (MEDP) will report second-quarter 2026 results on July 22, 2026, with investors watching whether the contract research organization can extend the robust growth it delivered in Q1 and maintain its elevated backlog conversion pace.
Revenue in the first quarter of 2026 rose 26.5% to $706.6 million, up from $558.6 million a year earlier, supported by continued demand across biotech and pharmaceutical customers. Backlog increased to $2.93 billion, while net new business awards grew 23.7% to $618.4 million, results in a book-to-bill ratio of 0.88x GAAP net income came in at $123.9 million, or $4.28 per share, compared with $114.6 million, or $3.67 per share in Q1 2025. EBIDTA rose 25.9% to $149.4 million, maintaining a margin of roughly 21%.
For full-year 2026, Medpace expects revenue of $2.755 billion to $2.855 billion, representing 8.9%-12.8% growth over FY2025 revenue of $2.530 billion.
GAAP net income is projected in the range of $487.0 million to $511.0 million, compared with FY2025 GAAP net income of $451.1 million, or $15.28 per share. EBITDA is expected to reach $605.0 million to $635.0 million, above FY2025 EBITDA of $557.7 million.
The company also highlighted strong liquidity, ending Q1, 2026 with $652.7 million in cash and generating $151.8 million in operating cash flow.
Q2 2025 Results
For the second-quarter of 2025, Medspace generated $603.3 million in revenue, up 14.2% from $528.1 million in Q2 2024.
GAAP net income for Q2 2025 was $90.3 million, or $3.10 per share, with EBITDA of $130.5 million and a margin of 21.6%.
About the Company
Medpace, headquartered in Cincinnati, Ohio, is a full-service clinical contract research organization (CRO) providing end-to-end development services to the biotech, pharmaceutical and medical device companies. It specializes in complex trials across oncology, cardiology, metabolic disease, and rare disorders, leveraging an integrated model to accelerate timelines while ensuring quality and compliance.
MEDP has traded between $306.70 and $628.92 over the past year. The stock closed Tuesday's trading at $530.68, up 0.52%.
For comments and feedback contact: editorial@rttnews.com
Business News
July 17, 2026 16:34 ET A slew of U.S. data was released during the week that threw light on trends in prices and spending. Separately, survey data reflected the consumer mood amid easing inflationary pressures. In Europe, economic output figures from the U.K. were the main news. Meanwhile, China dominated the economics news scene in Asia as the country released the latest gross domestic product and external trade data.